Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2025

A Risk Score Model Based on Drug-Sensitivity-Related Genes Has the Potential to Predict Oral Squamous Cell Carcinoma Prognosis.

View Full Paper
Ask AI
Bookmark
Share

Authors

YMYao MaYLYunpeng LiSDShih‐Torng Ding

Discussion

Loading...

Member takes

Overview

Model predicts prognosis in patients with oral squamous cell carcinoma, suggesting implications for immunotherapy strategies.

Key Points

  • The risk score model utilizes drug-sensitivity-related genes to estimate prognosis in oral squamous cell carcinoma.
  • Four key prognostic genes were identified: IGF2BP2, PLAU, CEP55, and CMYA5, enhancing prediction accuracy.
  • Patients were categorized into risk groups based on gene expression, showing distinct survival rates.
  • The model's prognostic value was validated, remaining independent of age, gender, and cancer stage.

Cite This Study

Ma et al. (2025) studied this question.

synapsesocial.com/papers/689522009f4f1c896c428f71https://doi.org/10.3290/j.ohpd.c_2124
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of a relapse-related RiskScore model to predict the drug sensitivity and prognosis for patients with ovarian cancer2025
  2. 2Identification of an Immunologic gene signature in prediction the prognosis and therapeutic responses of ovarian cancer2025
  3. 3An oxidative stress related gene signature predicts prognosis in cholangiocarcinoma2025
  4. 4Development and validation of G2M signature-based prognostic model for stratifying colon cancer prognosis2025
  5. 5A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer2025